Spartan Micro

Spartan Micro is a private, pre-revenue medical device company founded in 2017 and headquartered in Costa Mesa, California, despite its San Francisco registration. The company is developing the Spartan eCoil™ System for the neurovascular market, aiming to treat conditions like aneurysms with faster and safer procedures. It is in a late-stage development and production transition phase, preparing for regulatory submissions and subsequent commercial launch in key global markets. The company emphasizes a capital-efficient approach to product innovation and commercialization.

Focused platform for designing and manufacturing neurovascular embolization devices, specifically the Spartan eCoil™ System for endovascular treatment. Emphasizes a capital-efficient innovation process.

The neurovascular embolization coil market is highly competitive, dominated by large, integrated medical device companies like Stryker, Johnson & Johnson (Cerenovus), Medtronic, and Terumo. These competitors have extensive clinical data, strong brand loyalty, and broad product portfolios, creating high barriers to entry for a new, single-product company like Spartan Micro.